{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000982","form_type":"8-K","ticker":"SBEV","cik":"0001553788","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-07-29T20:31:21+00:00","discovered_at":"2026-07-29T20:32:00.321772+00:00","generated_at":"2026-07-29T20:32:19.613658+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Splash Beverage expands CannEpil license to veterinary applications, targets FDA approval","bullets":["Expanded exclusive global license for CannEpil to include veterinary therapeutics; royalty 10% of vet net revenue, 15% human.","Initial focus on canine oncology and chronic pain; global veterinary pain market ~$2.6B in 2024, projected $3.8B by 2030.","Company finalizing joint venture with established cannabinoid pharmaceutical firm to lead veterinary development program.","CannEpil is a pharmaceutical-grade CBD/THC oral solution with EU-GMP certification and IND for human program.","Will pursue FDA Center for Veterinary Medicine INAD and Conditional Approval pathways; no assurance of approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000982","json":"https://secwatch.observer/filing/0001731122-26-000982.json","markdown":"https://secwatch.observer/filing/0001731122-26-000982.md","text":"https://secwatch.observer/filing/0001731122-26-000982.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000982/0001731122-26-000982-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000982/e7811_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T20:32:19.613658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}